MedTrace Logo

The Effect of Psychodrama-Based Group Work

NCT07305571 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 23

Last updated 2026-01-06

No results posted yet for this study

Summary

Aims This study examined the effect of psychodrama-based group work on postpartum women's tendencies toward depression and forgiveness.

Methods This study used a pretest-posttest-follow-up randomised controlled experimental method. The study sample consisted of 23 postpartum mothers (11 experimental and 12 control) whose babies were receiving treatment in the neonatal intensive care unit between April and June 2025. While psychodrama-based group intervention was applied to the experimental group, no intervention was performed in the control group. Data were collected using a personal information form, Postnatal Depression Screening Scale, and Forgiveness Scale.

Results In the study, it was found that the mean forgiveness scores in the final test and follow-up measurements of the postpartum women in the experimental group were statistically significantly higher compared to the control group (p\<0.05). In the final test and follow-up measurements, the mean postpartum depression scores of the women in the experimental group were found to be statistically significantly lower than those of the mothers in the control group (p\<0.05).

Conclusions Psychodrama-based group work increased forgiveness tendencies and reduced depression levels in postpartum women. In this regard, it is recommended that psychodrama sessions be conducted for postpartum women.

Conditions

  • Psychiatric Nursing
  • Depression Disorder
  • Forgiveness
  • Puerperal Depression
  • Psychoeducation

Interventions

OTHER

psychodrama-based group intervention

For postpartum mothers in the experimental group, a psychodrama-based group intervention was carried out face-to-face, with one session per week, each lasting 120 minutes, for a total of 8 sessions (over 8 weeks).

OTHER

Control

no intervention was performed in the control group

Sponsors & Collaborators

  • Ömer USLU

    lead OTHER

Principal Investigators

  • Merve Şahin, PhD, RN · Bergama Necla Mithat Öztüre State Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-04-02
Primary Completion
2025-06-29
Completion
2025-06-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07305571 on ClinicalTrials.gov